GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HeiLongJiang ZBD Pharmaceutical Co Ltd (SHSE:603567) » Definitions » Operating Cash Flow per Share

HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) Operating Cash Flow per Share : ¥0.00 (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is HeiLongJiang ZBD Pharmaceutical Co Operating Cash Flow per Share?

HeiLongJiang ZBD Pharmaceutical Co's operating cash flow per share for the three months ended in Mar. 2025 was ¥-0.28. HeiLongJiang ZBD Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for HeiLongJiang ZBD Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, HeiLongJiang ZBD Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 139.20% per year. The lowest was -57.20% per year. And the median was 23.20% per year.

SHSE:603567's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.85
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

HeiLongJiang ZBD Pharmaceutical Co Operating Cash Flow per Share Historical Data

The historical data trend for HeiLongJiang ZBD Pharmaceutical Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeiLongJiang ZBD Pharmaceutical Co Operating Cash Flow per Share Chart

HeiLongJiang ZBD Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 -0.50 -0.35 -0.51 0.18

HeiLongJiang ZBD Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.12 0.04 0.36 -0.28

Competitive Comparison of HeiLongJiang ZBD Pharmaceutical Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, HeiLongJiang ZBD Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeiLongJiang ZBD Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HeiLongJiang ZBD Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HeiLongJiang ZBD Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.


;
;

HeiLongJiang ZBD Pharmaceutical Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

HeiLongJiang ZBD Pharmaceutical Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=164.308/939.975
=0.17

HeiLongJiang ZBD Pharmaceutical Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=-266.694/941.193
=-0.28

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeiLongJiang ZBD Pharmaceutical Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of HeiLongJiang ZBD Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


HeiLongJiang ZBD Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 72, Hongxing Street, Hulin Town, Heilongjiang Province, Hulin, CHN, 158400
HeiLongJiang ZBD Pharmaceutical Co Ltd operates as a pharmaceutical manufacturer. The business scope of the company includes wholesale, retail, traditional Chinese medicine decoction pieces, Chinese medicine formula granules, Chinese herbal medicine trade, medical equipment, sanitary materials, and inspection and testing.
Executives
Li Tian Zhu senior management
Zhang Zhong Fang Director
Wang Lei senior management
Yan Jiu Jiang Directors, senior managers
Li Xiu Zhen senior management
Li Xue Dong Supervisors

HeiLongJiang ZBD Pharmaceutical Co Headlines

No Headlines